Alcresta Therapeutics

Alcresta Therapeutics is a medical device manufacturer that makes RELiZORB, an FDA cleared enzyme cartridge that improves nutrient absorption during tube feeding for patients in need of enteral nutrition (“EN”) support (primarily patients with Cystic Fibrosis (”CF”) Pancreatitis, Pancreatic Cancer, Short Bowel Syndrome (“SBS”), and other acute conditions).

Recapitalization: Lender for a Senior Secured Credit Facility